Charles River Laboratories International to Initiate Comprehensive Review of its Business to Enhance Long-Term Stockholder Value

Published: 2025-05-07 09:02:00 ET CRL

Published on 05/07/2025 at 09:02, updated on 05/07/2025 at 12:36

Charles River Laboratories International, Inc. (NYSE:CRL) announced on May 7, 2025, that it had reached an agreement with activist investor Elliott Investment Management (Elliott Investment Management L.P.) and added four new directors to its board. The contract research firm, which has Elliott as its largest investor, said it will initiate a comprehensive review of its business, including an examination of various other alternatives to enhance long-term stockholder value. Make sense of the latest ESG trends affecting companies and governments with the Reuters Sustainable Switch newsletter.

The investor's exact stake in the company could not be determined.